These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 11429193)

  • 1. Application of nano-radiosensitizers in non-small cell lung cancer.
    Hu X; Hu J; Pang Y; Wang M; Zhou W; Xie X; Zhu C; Wang X; Sun X
    Front Oncol; 2024; 14():1372780. PubMed ID: 38646428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatment.
    Anastasov N; Höfig I; Radulović V; Ströbel S; Salomon M; Lichtenberg J; Rothenaigner I; Hadian K; Kelm JM; Thirion C; Atkinson MJ
    BMC Cancer; 2015 Jun; 15():466. PubMed ID: 26059545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G2 checkpoint abrogator abates the antagonistic interaction between antimicrotubule drugs and radiation therapy.
    Sui M; Zhang H; Di X; Chang J; Shen Y; Fan W
    Radiother Oncol; 2012 Aug; 104(2):243-8. PubMed ID: 22682751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.
    Loprevite M; Favoni RE; de Cupis A; Pirani P; Merlo F; Grossi F; Ardizzoni A
    Int J Oncol; 1999 Oct; 15(4):787-92. PubMed ID: 10493963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines.
    Loprevite M; Tiseo M; Grossi F; Scolaro T; Semino C; Pandolfi A; Favoni R; Ardizzoni A
    Oncol Res; 2005; 15(1):39-48. PubMed ID: 15839304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro study of farnesyltransferase inhibitor SCH 66336, in combination with chemotherapy and radiation, in non-small cell lung cancer cell lines.
    Loprevite M; Favoni RE; De Cupis A; Scolaro T; Semino C; Mazzanti P; Ardizzoni A
    Oncol Rep; 2004 Feb; 11(2):407-14. PubMed ID: 14719076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.
    Tolis C; Peters GJ; Ferreira CG; Pinedo HM; Giaccone G
    Eur J Cancer; 1999 May; 35(5):796-807. PubMed ID: 10505042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
    Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G
    Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines.
    Loprevite M; Favoni RE; de Cupis A; Pirani P; Pietra G; Bruno S; Grossi F; Scolaro T; Ardizzoni A
    Lung Cancer; 2001 Jul; 33(1):27-39. PubMed ID: 11429193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
    Bishop JF
    Lung Cancer; 1995 Jun; 12 Suppl 2():S53-61. PubMed ID: 7551950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.